Tuan H Nguyen, MD | |
4045 E Belknap St, Suite 12, Haltom City, TX 76111-6638 | |
(817) 759-2315 | |
(817) 759-2316 |
Full Name | Tuan H Nguyen |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 27 Years |
Location | 4045 E Belknap St, Haltom City, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881663193 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | K7191 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Methealth Pa | 2769786698 | 2 |
News Archive
Much has been written about the enormous effort required to take scientific discovery from the laboratory bench to the patient's bedside.
Surefire Medical, Inc., developer of a new class of infusion systems designed to maximize direct-to-tumor drug delivery, announced today that the company has received 510(k) FDA clearance and the CE Mark for its enhanced line of Surefire Guiding Catheters used in radioembolization and chemoembolization procedures.
A quick and simple technique to characterize breast cancer cells may expedite and improve treatment decisions, researchers from the University of Illinois at Chicago report in the journal of Experimental and Molecular Pathology.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has completed its targeted enrollment of 60 patients in the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT™ in patients with non-squamous non-small cell lung cancer (NSCLC).
Not just for teens anymore - social networking and media tools such as Facebook, Twitter and YouTube are being used by adults to interact with their friends, families and to gain information.
› Verified 2 days ago
Entity Name | Methealth Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205292638 PECOS PAC ID: 2769786698 Enrollment ID: O20160212000886 |
News Archive
Much has been written about the enormous effort required to take scientific discovery from the laboratory bench to the patient's bedside.
Surefire Medical, Inc., developer of a new class of infusion systems designed to maximize direct-to-tumor drug delivery, announced today that the company has received 510(k) FDA clearance and the CE Mark for its enhanced line of Surefire Guiding Catheters used in radioembolization and chemoembolization procedures.
A quick and simple technique to characterize breast cancer cells may expedite and improve treatment decisions, researchers from the University of Illinois at Chicago report in the journal of Experimental and Molecular Pathology.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has completed its targeted enrollment of 60 patients in the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT™ in patients with non-squamous non-small cell lung cancer (NSCLC).
Not just for teens anymore - social networking and media tools such as Facebook, Twitter and YouTube are being used by adults to interact with their friends, families and to gain information.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Tuan H Nguyen, MD 4045 E Belknap St Ste 12, Haltom City, TX 76111-6637 Ph: (817) 759-2315 | Tuan H Nguyen, MD 4045 E Belknap St, Suite 12, Haltom City, TX 76111-6638 Ph: (817) 759-2315 |
News Archive
Much has been written about the enormous effort required to take scientific discovery from the laboratory bench to the patient's bedside.
Surefire Medical, Inc., developer of a new class of infusion systems designed to maximize direct-to-tumor drug delivery, announced today that the company has received 510(k) FDA clearance and the CE Mark for its enhanced line of Surefire Guiding Catheters used in radioembolization and chemoembolization procedures.
A quick and simple technique to characterize breast cancer cells may expedite and improve treatment decisions, researchers from the University of Illinois at Chicago report in the journal of Experimental and Molecular Pathology.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has completed its targeted enrollment of 60 patients in the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT™ in patients with non-squamous non-small cell lung cancer (NSCLC).
Not just for teens anymore - social networking and media tools such as Facebook, Twitter and YouTube are being used by adults to interact with their friends, families and to gain information.
› Verified 2 days ago
Mark Shane Bickley, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 2900 Denton Hwy Ste A, Haltom City, TX 76117 Phone: 817-831-2012 Fax: 817-831-0134 | |
Dr. Timothy Brian Jones, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6340 N Beach St, Haltom City, TX 76137 Phone: 817-514-8668 Fax: 817-514-6778 | |
Dr. Keith Dwight Harbour, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 3233 Denton Hwy, Haltom City, TX 76117 Phone: 817-838-2381 Fax: 817-838-2391 | |
Mai V Hoang, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4045 E Belknap St, #12, Haltom City, TX 76111 Phone: 817-759-2315 Fax: 817-759-2316 | |
Martha Jean Chapman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6201 Mccullar St, Haltom City, TX 76117 Phone: 817-834-6068 |